Exploring the Positive Thinking of Patients With Prostate Cancer: Self-efficacy as a Mediator

Cancer Nurs. 2022 Mar-Apr;45(2):E329-E337. doi: 10.1097/NCC.0000000000000868.

Abstract

Background: Research has explored the effectiveness of positive thinking on individuals, but only a few studies have investigated the factors that influence individual positive thinking, particularly among patients with prostate cancer.

Objectives: The aim of this study was to understand the factors that affect positive thinking among patients with prostate cancer and the mediating role of self-efficacy.

Methods: A cross-sectional design and a convenience sampling method were used to recruit patients with prostate cancer from 2 hospitals in Taiwan. Structured scales were used for data collection, including the General Self-efficacy Scale, Expanded Prostate Cancer Index Composite, Positive Thinking Scale, and Social Support Scale.

Results: The total average score for positive thinking among 201 patients was 66.1 (SD, 9.4). The factors that influenced the positive thinking of patients with prostate cancer included self-efficacy, treatment satisfaction, perceived health status, marital status, and appraisal support. The effects of treatment satisfaction and appraisal support on positive thinking were partly achieved through self-efficacy (partial mediation).

Conclusions: Self-efficacy is a mediator that affects the relationship of treatment satisfaction, appraisal support, and positive thinking.

Implications for practice: In the course of the disease, healthcare providers can help patients with prostate cancer to promote and maintain appropriate positive thinking by improving treatment satisfaction; increasing appraisal support from family, relatives, and friends; strengthening self-efficacy; and modifying unrealistic expectations.

MeSH terms

  • Cross-Sectional Studies
  • Humans
  • Male
  • Optimism
  • Prostatic Neoplasms* / therapy
  • Self Efficacy*
  • Social Support